An open-label, randomized clinical trial assessing immunogenicity, safety and tolerability of pandemic influenza A/H1N1 MF59-adjuvanted vaccine administered sequentially or simultaneously with seasonal virosomal-adjuvanted influenza vaccine to paediatric kidney transplant recipients

Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection

(2010) Susanna Esposito et al.   JOURNAL OF CLINICAL VIROLOGY

Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period

(2010) Caterina Rizzo et al.   VACCINE

Decreased Antibody Response to Influenza Vaccination in Kidney Transplant Recipients: A Prospective Cohort Study

(2009) Kelly A. Birdwell et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Guidance on Novel Influenza A/H1N1 in Solid Organ Transplant Recipients†

(2009) D. Kumar et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Humoral and Cellular Immune Responses after Influenza Vaccination in Kidney Transplant Recipients

(2009) S Candon et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Randomized, Double‐Blind Comparative Trial of Subunit and Virosomal Influenza Vaccines for Immunocompromised Patients

(2009) John Evison et al.   CLINICAL INFECTIOUS DISEASES

Influenza virus vaccination in kidney transplant recipients: serum antibody response to different immunosuppressive drugs

(2009) Mauro J.C. Salles et al.   CLINICAL TRANSPLANTATION

The rational use of influenza vaccines in healthy children and children with underlying conditions

(2009) Susanna Esposito et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Immunogenicity of a Monovalent 2009 Influenza A(H1N1) Vaccine in Infants and Children

(2009) Terry Nolan et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Large trials confirm immunogenicity of H1N1 vaccines

(2009) Heath Kelly et al.   LANCET

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial

(2009) Xiao-Feng Liang et al.   LANCET

Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009–10 influenza season: a multicentre, randomised controlled trial

(2009) Zoltan Vajo et al.   LANCET

Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses

(2009) Ken M Kunisaki et al.   LANCET INFECTIOUS DISEASES

Response to a Monovalent 2009 Influenza A (H1N1) Vaccine

(2009) Michael E. Greenberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Novel Influenza A (H1N1) Vaccine in Various Age Groups

(2009) Feng-Cai Zhu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine

(2009) Tristan W. Clark et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus

(2009) Kathy Hancock et al.   NEW ENGLAND JOURNAL OF MEDICINE

Enhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 Adjuvant

(2009) Timo Vesikari et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Antibody Response to Influenza Immunization in Kidney Transplant Recipients Receiving either Azathioprine or Mycophenolate: A Controlled Trial

(2008) Maryam Keshtkar-Jahromi et al.   AMERICAN JOURNAL OF NEPHROLOGY

Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: Five-year outcomes

(2008) Mysore S. Anil Kumar et al.   TRANSPLANT IMMUNOLOGY

Long-Term Efficacy of Induction Therapy With Anti–Interleukin-2 Receptor Antibodies or Thymoglobulin Compared With No Induction Therapy in Renal Transplantation

(2008) D.J. Taber et al.   TRANSPLANTATION PROCEEDINGS